Primigravida screening test a ‘game-changer’
Australian researchers have developed what they describe as a “game changing” blood test to determine a primigravida’s risk of the most common complications.
Until now predicting preeclampsia, preterm birth, intrauterine growth restriction and gestational diabetes has been difficult, says lead researcher Professor Claire Roberts, a specialist in paediatrics and reproductive health at the University of Adelaide.
The test, conducted at 12 weeks, involves taking blood from both parents. It uses algorithms to assess DNA in combination with clinical